[Objectives]To evaluate whether the level of serum uric acid in patients with bipolar disorder type I in their manic episode was different from that in healthy subjects,and to evaluate whether the level of serum uric ...[Objectives]To evaluate whether the level of serum uric acid in patients with bipolar disorder type I in their manic episode was different from that in healthy subjects,and to evaluate whether the level of serum uric acid is related to the severity of manic episode and the improvement of clinical symptoms.[Methods]A total of 70 patients with bipolar disorder type I in their manic episode were selected,their serum uric acid levels were measured at the beginning of the enrollment and at the end of the first,second and third week,and the clinical symptoms were evaluated with Young Mania Rating Scale(YMRS).65 healthy subjects were enrolled,and their serum uric acid levels were measured only at the beginning of the enrollment.[Results]The level of serum uric acid in patients with bipolar disorder type I in their manic episode was higher than that in healthy adults(t=8.153,p=0.039).At the end of the third week,the YMRS score and uric acid level of the patients were lower than those of the patients at the beginning of the enrollment(t=17.107,p=0.000;t=35.864,p=0.000).[Conclusions]The level of serum uric acid in patients with bipolar disorder type I in their manic episode was higher than that in healthy subjects,and the decrease of serum uric acid level may be related to the improvement of clinical symptoms.展开更多
BACKGROUND Nowadays there is an increasing use of transcranial magnetic stimulation(TMS)both in neurological and psychiatric fields.After Food and Drug Administration approval of TMS for the therapy of treatment-resis...BACKGROUND Nowadays there is an increasing use of transcranial magnetic stimulation(TMS)both in neurological and psychiatric fields.After Food and Drug Administration approval of TMS for the therapy of treatment-resistant depression,TMS has been widely used in the context of mood disorders(MD).However,growing reports regarding the possibility of developing hypomanic/manic switch(HMS)have generated concern regarding its use in MDs.AIM To investigate the actual risk of developing HMS due to TMS in the treatment of MD.METHODS We led our research on PubMed,Scopus and Web of Science on March 22,2020,in accordance to the PRISMA guidelines for systematic review.Only double blind/single blind studies,written in English and focused on the TMS treatment of MD,were included.A meta-analysis of repetitive TMS protocol studies including HMS was conducted using RevMan 5.4 software.The assessment of Risk of Bias was done using Cochrane risk of bias tool.This protocol was registered on PROSPERO with the CRD42020175811 code.RESULTS Twenty-five studies were included in our meta-analysis:Twenty-one double blind randomized controlled trials(RCT)and four single blind-RCT(no.of subjects involved in active stimulation=576;no.of subjects involved in sham protocol=487).The most frequently treated pathology was major depressive episode/major depressive disorder,followed by resistant depression,bipolar depression and other MD.The majority of the studies used a repetitive TMS protocol,and the left dorsolateral prefrontal cortex was the main target area.Side effects were reported in eight studies and HMS(described as greater energy,insomnia,irritability,anxiety,suicidal attempt)in four studies.When comparing active TMS vs sham treatment,the risk of developing HMS was not significantly different between conditions.CONCLUSION Applying the most usual protocols and the appropriate precautionary measures,TMS seems not to be related to HMS development.展开更多
Methylmalonic aciduria (MMA) is an autosomal recessive disorder of cobalamin (cbl) metabolism. Cobalamin C (cblC) disease is the most common type of MMA and is characteristically concurrent with homocystinemia ...Methylmalonic aciduria (MMA) is an autosomal recessive disorder of cobalamin (cbl) metabolism. Cobalamin C (cblC) disease is the most common type of MMA and is characteristically concurrent with homocystinemia (HCY) due to impaired synthesis of two active forms of cbl, namely adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl). The estimated worldwide incidence of MMA ranges between 1:48,000 and 1:250,000. Mutations of the MMA and HCY type C protein (MMACtfC) gene are responsible for cblC disease and were first identified by Lerner-Ellis et aL in 2006.By the year 2016, more than 82 different MMACHC gene mutations have been reported (http:// www.hgmd.cf.ac.uk/ac/index.php). Among these mutations, c.609G〉A (p.W203X) was reported to be the most frequent cblC mutation in Chinese patients.展开更多
目的 比较双相障碍躁狂发作和抑郁障碍患者心理理论(theory of mind,ToM)损害及其错误类型与临床症状的相关性。方法 纳入躁狂发作患者54例,抑郁障碍患者54例,健康对照者52名。采用中文版社会认知视频测查工具(Chinese version of the m...目的 比较双相障碍躁狂发作和抑郁障碍患者心理理论(theory of mind,ToM)损害及其错误类型与临床症状的相关性。方法 纳入躁狂发作患者54例,抑郁障碍患者54例,健康对照者52名。采用中文版社会认知视频测查工具(Chinese version of the movie for the assessment of social cognition,MASC-C)评估被试ToM能力,计算被试在MASC-C任务中正确得分及三种错误ToM得分(包括“ToM-过度”、“ToM-不足”及“没有-ToM”)。躁狂发作组采用杨氏躁狂量表(Young manic rating scale,YMRS)评定躁狂症状,抑郁障碍组使用24项汉密尔顿抑郁量表(24-item Hamilton depression scale,HAMD-24)评估抑郁症状。结果 躁狂发作组和抑郁障碍组MASC-C总分均低于对照组[25.0(23.0,28.0)、29.5(25.0,32.0) vs. 31.5(29.3,33.0),均P<0.01]。躁狂发作组“ToM-过度”得分高于其他两组[9.5(8.0,10.0) vs. 6.0(3.8,7.3)、5.0(3.3,6.0),均P<0.01],躁狂发作组、抑郁障碍组“ToM-不足”得分高于对照组[5.0(4.0,7.0)、6.0(4.0,7.3) vs. 5.0(4.0,6.0),P<0.05]。MASC-C总分与YMRS量表分(r=-0.277,P=0.042)、HAMD-24量表分(r=-0.635,P<0.001)呈负相关,“ToM-过度”得分与YMRS量表分呈正相关(r=0.460,P<0.001),“没有-ToM”得分与HAMD-24量表分呈正相关(r=0.540,P<0.001)。结论 躁狂发作及抑郁障碍患者均存在不同程度的ToM损害,躁狂发作ToM损害重于抑郁障碍,且主要表现为过度加工,抑郁障碍则主要表现为加工不足,情感症状的严重程度与ToM损害有关,ToM损害可能是情感性精神障碍的核心特征。展开更多
文摘[Objectives]To evaluate whether the level of serum uric acid in patients with bipolar disorder type I in their manic episode was different from that in healthy subjects,and to evaluate whether the level of serum uric acid is related to the severity of manic episode and the improvement of clinical symptoms.[Methods]A total of 70 patients with bipolar disorder type I in their manic episode were selected,their serum uric acid levels were measured at the beginning of the enrollment and at the end of the first,second and third week,and the clinical symptoms were evaluated with Young Mania Rating Scale(YMRS).65 healthy subjects were enrolled,and their serum uric acid levels were measured only at the beginning of the enrollment.[Results]The level of serum uric acid in patients with bipolar disorder type I in their manic episode was higher than that in healthy adults(t=8.153,p=0.039).At the end of the third week,the YMRS score and uric acid level of the patients were lower than those of the patients at the beginning of the enrollment(t=17.107,p=0.000;t=35.864,p=0.000).[Conclusions]The level of serum uric acid in patients with bipolar disorder type I in their manic episode was higher than that in healthy subjects,and the decrease of serum uric acid level may be related to the improvement of clinical symptoms.
文摘BACKGROUND Nowadays there is an increasing use of transcranial magnetic stimulation(TMS)both in neurological and psychiatric fields.After Food and Drug Administration approval of TMS for the therapy of treatment-resistant depression,TMS has been widely used in the context of mood disorders(MD).However,growing reports regarding the possibility of developing hypomanic/manic switch(HMS)have generated concern regarding its use in MDs.AIM To investigate the actual risk of developing HMS due to TMS in the treatment of MD.METHODS We led our research on PubMed,Scopus and Web of Science on March 22,2020,in accordance to the PRISMA guidelines for systematic review.Only double blind/single blind studies,written in English and focused on the TMS treatment of MD,were included.A meta-analysis of repetitive TMS protocol studies including HMS was conducted using RevMan 5.4 software.The assessment of Risk of Bias was done using Cochrane risk of bias tool.This protocol was registered on PROSPERO with the CRD42020175811 code.RESULTS Twenty-five studies were included in our meta-analysis:Twenty-one double blind randomized controlled trials(RCT)and four single blind-RCT(no.of subjects involved in active stimulation=576;no.of subjects involved in sham protocol=487).The most frequently treated pathology was major depressive episode/major depressive disorder,followed by resistant depression,bipolar depression and other MD.The majority of the studies used a repetitive TMS protocol,and the left dorsolateral prefrontal cortex was the main target area.Side effects were reported in eight studies and HMS(described as greater energy,insomnia,irritability,anxiety,suicidal attempt)in four studies.When comparing active TMS vs sham treatment,the risk of developing HMS was not significantly different between conditions.CONCLUSION Applying the most usual protocols and the appropriate precautionary measures,TMS seems not to be related to HMS development.
文摘Methylmalonic aciduria (MMA) is an autosomal recessive disorder of cobalamin (cbl) metabolism. Cobalamin C (cblC) disease is the most common type of MMA and is characteristically concurrent with homocystinemia (HCY) due to impaired synthesis of two active forms of cbl, namely adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl). The estimated worldwide incidence of MMA ranges between 1:48,000 and 1:250,000. Mutations of the MMA and HCY type C protein (MMACtfC) gene are responsible for cblC disease and were first identified by Lerner-Ellis et aL in 2006.By the year 2016, more than 82 different MMACHC gene mutations have been reported (http:// www.hgmd.cf.ac.uk/ac/index.php). Among these mutations, c.609G〉A (p.W203X) was reported to be the most frequent cblC mutation in Chinese patients.
文摘目的 比较双相障碍躁狂发作和抑郁障碍患者心理理论(theory of mind,ToM)损害及其错误类型与临床症状的相关性。方法 纳入躁狂发作患者54例,抑郁障碍患者54例,健康对照者52名。采用中文版社会认知视频测查工具(Chinese version of the movie for the assessment of social cognition,MASC-C)评估被试ToM能力,计算被试在MASC-C任务中正确得分及三种错误ToM得分(包括“ToM-过度”、“ToM-不足”及“没有-ToM”)。躁狂发作组采用杨氏躁狂量表(Young manic rating scale,YMRS)评定躁狂症状,抑郁障碍组使用24项汉密尔顿抑郁量表(24-item Hamilton depression scale,HAMD-24)评估抑郁症状。结果 躁狂发作组和抑郁障碍组MASC-C总分均低于对照组[25.0(23.0,28.0)、29.5(25.0,32.0) vs. 31.5(29.3,33.0),均P<0.01]。躁狂发作组“ToM-过度”得分高于其他两组[9.5(8.0,10.0) vs. 6.0(3.8,7.3)、5.0(3.3,6.0),均P<0.01],躁狂发作组、抑郁障碍组“ToM-不足”得分高于对照组[5.0(4.0,7.0)、6.0(4.0,7.3) vs. 5.0(4.0,6.0),P<0.05]。MASC-C总分与YMRS量表分(r=-0.277,P=0.042)、HAMD-24量表分(r=-0.635,P<0.001)呈负相关,“ToM-过度”得分与YMRS量表分呈正相关(r=0.460,P<0.001),“没有-ToM”得分与HAMD-24量表分呈正相关(r=0.540,P<0.001)。结论 躁狂发作及抑郁障碍患者均存在不同程度的ToM损害,躁狂发作ToM损害重于抑郁障碍,且主要表现为过度加工,抑郁障碍则主要表现为加工不足,情感症状的严重程度与ToM损害有关,ToM损害可能是情感性精神障碍的核心特征。